Did the FDA Move Too Slowly in Fully Approving the Pfizer-BioNTech Vaccine?

Did the FDA Move Too Slowly in Fully Approving the Pfizer-BioNTech Vaccine?

Submitted by admin on September 6, 2021 - 6:38pm
Source: 
Motley Fool
News Tags: 
FDA
Pfizer
BioNTech
vaccines
COVID-19
Headline: 
Did the FDA Move Too Slowly in Fully Approving the Pfizer-BioNTech Vaccine?
snippet: 
  • The FDA had to perform a balancing act during the review process for Pfizer and BioNTech's COVID-19 vaccine.
  • For the agency to have moved more quickly would likely have required it to divert resources from reviewing other drugs and vaccines.

Do Not Allow Advertisers to Use My Personal information